Tissue bioengineering for surgical bleb defects: An animal study

Wei Cherng Hsu, Robert Ritch, Theodore Krupin, Henry Shen Lih Chen

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Background: To assess the effectiveness of OloGen (also named iGen), a porous, bioengineered, biodegradable, collagen-glycoaminoglycan matrix implant, in preventing poor bleb formation and early failure after trabeculectomy in eyes with a surgical wound defect. Methods: The right eyes of 30 female New Zealand albino rabbits underwent trabeculectomy with OloGen implanted subconjunctivally on top of the scleral flap, while six right eyes received trabeculectomy without the implant to serve as a control group. A 1-2 mm diameter circular conjunctival defect was created in all eyes. Six rabbits in the group receiving the implant were sacrificed on days 3, 5, 7, 21, and 28. Rabbits in the control group were sacrificed on day 28. Perkins applanation tonometry, Seidel test and measurement of both the extent of the conjunctival defect and the anterior chamber depth were performed. Enucleated eyes were fixed in 4% formaldehyde and stained with hematoxylin and eosin (H&E) for general histological observation, and with Sirius and Fast-green stains to assess collagen deposition and cell migration. Results: Seidel tests were negative for all operated and control eyes. No flat anterior chamber occurred in either group. With the exception of days 5 and 7, post-operative mean IOP difference is significant in both groups, (P>0.05 for day 5, 7 and P

Original languageEnglish
Pages (from-to)709-717
Number of pages9
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Volume246
Issue number5
DOIs
Publication statusPublished - May 2008

Fingerprint

Bioengineering
Blister
Trabeculectomy
Anterior Chamber
Rabbits
Collagen
Control Groups
Manometry
Hematoxylin
Eosine Yellowish-(YS)
Formaldehyde
Cell Movement
Coloring Agents
Observation

Keywords

  • Biodegradable
  • Collagen matrix
  • Glaucoma
  • Implant
  • Tissue engineering
  • Trabeculectomy
  • Wound healing

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Tissue bioengineering for surgical bleb defects : An animal study. / Hsu, Wei Cherng; Ritch, Robert; Krupin, Theodore; Chen, Henry Shen Lih.

In: Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 246, No. 5, 05.2008, p. 709-717.

Research output: Contribution to journalArticle

Hsu, Wei Cherng ; Ritch, Robert ; Krupin, Theodore ; Chen, Henry Shen Lih. / Tissue bioengineering for surgical bleb defects : An animal study. In: Graefe's Archive for Clinical and Experimental Ophthalmology. 2008 ; Vol. 246, No. 5. pp. 709-717.
@article{1df98a1f287f447ab0dec579a062fcf7,
title = "Tissue bioengineering for surgical bleb defects: An animal study",
abstract = "Background: To assess the effectiveness of OloGen (also named iGen), a porous, bioengineered, biodegradable, collagen-glycoaminoglycan matrix implant, in preventing poor bleb formation and early failure after trabeculectomy in eyes with a surgical wound defect. Methods: The right eyes of 30 female New Zealand albino rabbits underwent trabeculectomy with OloGen implanted subconjunctivally on top of the scleral flap, while six right eyes received trabeculectomy without the implant to serve as a control group. A 1-2 mm diameter circular conjunctival defect was created in all eyes. Six rabbits in the group receiving the implant were sacrificed on days 3, 5, 7, 21, and 28. Rabbits in the control group were sacrificed on day 28. Perkins applanation tonometry, Seidel test and measurement of both the extent of the conjunctival defect and the anterior chamber depth were performed. Enucleated eyes were fixed in 4{\%} formaldehyde and stained with hematoxylin and eosin (H&E) for general histological observation, and with Sirius and Fast-green stains to assess collagen deposition and cell migration. Results: Seidel tests were negative for all operated and control eyes. No flat anterior chamber occurred in either group. With the exception of days 5 and 7, post-operative mean IOP difference is significant in both groups, (P>0.05 for day 5, 7 and P",
keywords = "Biodegradable, Collagen matrix, Glaucoma, Implant, Tissue engineering, Trabeculectomy, Wound healing",
author = "Hsu, {Wei Cherng} and Robert Ritch and Theodore Krupin and Chen, {Henry Shen Lih}",
year = "2008",
month = "5",
doi = "10.1007/s00417-007-0744-9",
language = "English",
volume = "246",
pages = "709--717",
journal = "Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie",
issn = "0065-6100",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Tissue bioengineering for surgical bleb defects

T2 - An animal study

AU - Hsu, Wei Cherng

AU - Ritch, Robert

AU - Krupin, Theodore

AU - Chen, Henry Shen Lih

PY - 2008/5

Y1 - 2008/5

N2 - Background: To assess the effectiveness of OloGen (also named iGen), a porous, bioengineered, biodegradable, collagen-glycoaminoglycan matrix implant, in preventing poor bleb formation and early failure after trabeculectomy in eyes with a surgical wound defect. Methods: The right eyes of 30 female New Zealand albino rabbits underwent trabeculectomy with OloGen implanted subconjunctivally on top of the scleral flap, while six right eyes received trabeculectomy without the implant to serve as a control group. A 1-2 mm diameter circular conjunctival defect was created in all eyes. Six rabbits in the group receiving the implant were sacrificed on days 3, 5, 7, 21, and 28. Rabbits in the control group were sacrificed on day 28. Perkins applanation tonometry, Seidel test and measurement of both the extent of the conjunctival defect and the anterior chamber depth were performed. Enucleated eyes were fixed in 4% formaldehyde and stained with hematoxylin and eosin (H&E) for general histological observation, and with Sirius and Fast-green stains to assess collagen deposition and cell migration. Results: Seidel tests were negative for all operated and control eyes. No flat anterior chamber occurred in either group. With the exception of days 5 and 7, post-operative mean IOP difference is significant in both groups, (P>0.05 for day 5, 7 and P

AB - Background: To assess the effectiveness of OloGen (also named iGen), a porous, bioengineered, biodegradable, collagen-glycoaminoglycan matrix implant, in preventing poor bleb formation and early failure after trabeculectomy in eyes with a surgical wound defect. Methods: The right eyes of 30 female New Zealand albino rabbits underwent trabeculectomy with OloGen implanted subconjunctivally on top of the scleral flap, while six right eyes received trabeculectomy without the implant to serve as a control group. A 1-2 mm diameter circular conjunctival defect was created in all eyes. Six rabbits in the group receiving the implant were sacrificed on days 3, 5, 7, 21, and 28. Rabbits in the control group were sacrificed on day 28. Perkins applanation tonometry, Seidel test and measurement of both the extent of the conjunctival defect and the anterior chamber depth were performed. Enucleated eyes were fixed in 4% formaldehyde and stained with hematoxylin and eosin (H&E) for general histological observation, and with Sirius and Fast-green stains to assess collagen deposition and cell migration. Results: Seidel tests were negative for all operated and control eyes. No flat anterior chamber occurred in either group. With the exception of days 5 and 7, post-operative mean IOP difference is significant in both groups, (P>0.05 for day 5, 7 and P

KW - Biodegradable

KW - Collagen matrix

KW - Glaucoma

KW - Implant

KW - Tissue engineering

KW - Trabeculectomy

KW - Wound healing

UR - http://www.scopus.com/inward/record.url?scp=42049103238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42049103238&partnerID=8YFLogxK

U2 - 10.1007/s00417-007-0744-9

DO - 10.1007/s00417-007-0744-9

M3 - Article

C2 - 18265997

AN - SCOPUS:42049103238

VL - 246

SP - 709

EP - 717

JO - Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie

JF - Albrecht von Graefes Archiv für Klinische und Experimentelle Ophthalmologie

SN - 0065-6100

IS - 5

ER -